Venous thromboembolism among new users of different oral contraceptives

被引：93

作者：

Herings, RMC ^{[1
]}

Urquhart, J ^{[1
]}

Leufkens, HGM ^{[1
]}

机构：

[1] Dept Pharmacoepidemiol & Pharmacotherapy, NL-3508 TB Utrecht, Netherlands

来源：

LANCET | 1999年 / 354卷 / 9173期

关键词：

D O I：

10.1016/S0140-6736(99)01257-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

New use of third generation oral contraceptives is associated with a four-fold increased risk of venous thromboembolism compared with users of second generation oral contraceptives, particularly among young, healthy women.

引用

页码：127 / 128

页数：2

共 5 条

[1] PHARMACO-MORBIDITY LINKAGE - A FEASIBILITY STUDY COMPARING MORBIDITY IN 2 PHARMACY BASED EXPOSURE COHORTS
HERINGS, RMC
BAKKER, A
STRICKER, BHC
NAP, G
[J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1992, 46 (02) : 136 - 140
[2] HERINGS RMC, 1993, THESIS UTRECHT U UTR
[3] HERINGS RMC, 1996, PHARMACOEPIDEM DR S, V5, P88
[4] Third-generation oral contraceptive and deep venous thrombosis: From epidemiologic controversy to new insight in coagulation
Vandenbroucke, JP
Helmerhorst, FM
Bloemenkamp, KWM
Rosendaal, FR
[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 177 (04) : 887 - 891
[5] Newer oral contraceptives and the risk of venous thromboembolism
Walker, AM
[J]. CONTRACEPTION, 1998, 57 (03) : 169 - 181

← 1 →